Lipid nanoparticles (LNPs) are biocompatible and biodegradable nanoparticles used for the delivery of therapeutic agents, such as drugs, RNA, and DNA. LNPs consist of a phospholipid bilayer that encapsulates a hydrophobic core made up of cholesterol and other lipids. The therapeutic agent is encapsulated within the core and delivered to the target site. LNPs have several advantages over other drug delivery systems. They are highly efficient in delivering hydrophobic drugs to target sites and can protect the drug from clearance by the immune system. They also have a high drug loading capacity, and the encapsulated drug is protected from degradation. The global lipid nanoparticles market size is projected to grow by USD 295.7 million from 2023 to 2029, registering a CAGR of 7.44 percent, according to the latest market data.
This industry report offers market estimates of the global market, followed by a detailed analysis of the product, application, and region. The global market data on lipid nanoparticles can be segmented by product: mRNA-lipid nanoparticles, siRNA-lipid nanoparticles, others. According to the research, the mRNA-lipid nanoparticles segment had the largest share in the global lipid nanoparticles market. Lipid nanoparticles market is further segmented by application: scientific research, vaccines and drugs. In 2022, the vaccines and drugs segment made up the largest share of revenue generated by the lipid nanoparticles market. Based on region, the lipid nanoparticles market is segmented into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. Among these, North America was accounted for the highest revenue generator in 2022.
The global lipid nanoparticles market is highly competitive. Key companies profiled in the report include Avanti Polar Lipids Inc., Evonik Industries AG, Exelead Inc., Genevant Sciences GmbH, Lipoid GmbH, Merck KGaA, Nippon Fine Chemical Co. Ltd., Precision NanoSystems Inc.
The data-centric report focuses on market trends, status and outlook for segments. With comprehensive market assessment across the major geographies, the report is a valuable asset for the existing players, new entrants and the future investors.
Why buy this report?
• Get a detailed picture of the Global Lipid Nanoparticles Market
• Identify segments/areas to invest in over the forecast period in the Global Lipid Nanoparticles Market
• Understand the competitive environment, the market’s leading players
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.
| REPORT ATTRIBUTE | DETAILS |
|---|---|
| Base Year | 2022 |
| Forecast Year | 2023-2029 |
| CAGR (2023-2029) | 7.44% |
| Pages | 20 |
| Key Players | Avanti Polar Lipids Inc., Evonik Industries AG, Exelead Inc., Genevant Sciences GmbH, Lipoid GmbH, Merck KGaA, Nippon Fine Chemical Co. Ltd., Precision NanoSystems Inc. |
The global dental burs market is projected to expand at a CAGR of ~5.6 percent across the forecast period of 2024 – 2030, according to the latest edition of the…
The global urology laser market is estimated to increase at the rate of 5.6% each year in the period from 2023 to 2029. Urology lasers are medical devices specifically designed…
The global scar management market, in terms of revenue, is anticipated to progress at a CAGR of 5.8% during the forecast period, 2023-2029. Scar management encompasses various techniques and treatments…
Please fill out our form and we will get back to you.
